FeetMe is a digital health startup based in France, founded in 2013, focusing on improving patient outcomes in functional care, tracking disease advancement, and enhancing medication usage. The company's groundbreaking technology utilizes pressure sensors, motion sensors, and learning algorithms to enable real-time analysis of gait and posture in day-to-day situations. This innovative approach facilitates the evaluation of patients' functional aptitude, particularly beneficial for those diagnosed with gait disorders. The company recently secured a €6.00M Convertible Note investment on 29 March 2022, with participation from notable investors including SOSV, HAX, Kurma Partners, and LBO France. FeetMe's commitment to leveraging connected technologies and services to revolutionize patient care in the healthcare industry makes it an exciting prospect for potential investors and signifies its potential for significant growth and impact in the near future. For more information, visit www.feetme.fr.
Funding Stage | Amount | No. Investors | Investors | Date |
---|---|---|---|---|
Series B | Unknown | 2 | 06 Jun 2024 | |
Convertible Note | €6.00M | 4 | 29 Mar 2022 | |
Series A | €9.40M | 7 | Partech, Paris-Saclay Seed Fund | 24 Sep 2019 |
Seed Round | $2.28M | 5 | Paris-Saclay Seed Fund | 05 Oct 2017 |
Seed Round | Unknown | 2 | 04 Feb 2015 |
No recent news or press coverage available for FeetMe.